MicroRNA Market is estimated to be US$ 3844.3 million by 2032 with a CAGR of 16.0% over the forecast period (2022-2032)

 

MicroRNA are used by cells to control expression of gene. MicroRNA molecules are found in blood and cells. MicroRNA up regulate or down regulate in various inflammatory and infectious disease. MicroRNA are determine to play major role in different range of developmental process which includes, cell proliferation, metabolism, apoptosis, neuronal cell fate and developmental timing. MicroRNA function as tumor suppressors or oncogenes under specific conditions. MicroRNA is a biomarker as it meet most of the required criteria to be an ideal biomarker such as high specificity, accessibility and sensitivity. MicroRNA regulate gene expression post transcriptionally. PTEN and TP53 genes are regulated by the MicroRNA. By repressing protein expression & by promoting mRNA decay MicroRNA silence the expression of gene. MicroRNA target an average of 100 to 200 genes. MicroRNA has become the potential biomarkers for diagnosis, prognosis, and therapeutic target of human cancer. MicroRNA are produced by transcription of miRNA genes in nucleus which is known as miRNA precursor genes. MicroRNA play an important role in estimating the development, prognosis, progression, diagnosis, & treatment response in cancer patients. MicroRNA helps in targeting apoptotic genes by mediating tumorigenesis. MicroRNA provides capability of cancer stem cells for evading G1/S checkpoint. MicroRNA also paly vital role in p53 tumor suppressor pathways. miR-451 is a potential prognostic biomarker in head & neck squamous cell carcinomas. MicroRNA regulate the immune response, development of immune cell and prevention of autoimmunity. MicroRNA plays an important role in regulating immune-inflammatory response. MicroRNA are also involved in regulating TLRs (toll-like receptors) in periodontal inflammation. MicroRNA which are extracellular are isolated from body fluids like plasma, serum and saliva. These extracellular MicroRNA are act as a potential biomarker for detecting various diseases. Salivary MicroRNAs are used in detecting oral cancer. Salivary exosomal MicroRNAs plays important role in diagnostic tool and also provides information regarding the role of MicroRNAs in pathophysiology of various salivary gland disease. Quantitative PCR (q-PCR) and Microarray methods are major modalities used for profiling MicroRNAs. Quantitative PCR method is inexpensive and widely used which allows the measurement of minute quantities of MicroRNAs. However, wide variety of applications has given positive impact on target market growth.

The report “MicroRNA Market, By Technology (Microarray, Real Time PCR, Next Generation Sequencing, and Others), By Application (Cardiovascular disease, Cancer, Neurological disease, Infectious disease, Immunological disorder, and Others), By End-Users (Pharmaceutical & Biotechnology Companies, Research Institutes, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2032”

Key Highlights:

·         In July 2019, miRFA an automated pipeline for microRNA functional analysis with correlation support from TCGA & TCPA expression data in pancreatic cancer. Fifteen circulating miRNAs with significantly altered expression levels were detected in pancreatic cancer patients was queried separately in pipeline. It was concluded that miRNA functional analysis pipeline serve as a valuable tool in biomarker discovery involves mature microRNA associated with pancreatic cancer & developed to cover additional cancer types.

·         In February 2019, PmiRDiscVali an integrated pipeline for plant microRNA discovery & validation. It was concluded that integrated pipeline PmiRDiscVali, is featured with degradome-seq-data-based validation & vivid result presentation will be useful for large scale identification of plant miRNA candidates.

Analyst View:

The key factor for driving MicroRNA market is rising prevalence of cancer diseases and rapid growth in urban population. Rising urbanization has significant impact on cancer morbidity due to risk factors like more pollution in urban areas, poor nutrition food, lack of exercise, smoking, alcohol intake, etc. MicroRNA act as a potential biomarker for detecting various diseases like cancer, heart disease, infectious disease, etc. MicroRNA helps in diagnosis, prognosis, and treating of cancer diseases. Using MicroRNA-based therapy provides advantages which includes ability to rapidly develop new therapies and ability to target several genes in given pathway. MicroRNA has become the promising candidate for development of biomarkers. Multiple technological platforms are developed for miRNA isolation, miRNA profiling, miRNA quantitation, miRNA target detection and modulating miRNA levels in-vitro and in-vivo. However, application in cancer diagnosis is expected to boosts the growth of target market over the forecast period. As a result, market competition is intensifying, and both big international corporations and start-ups are vying to establish position in the market.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “MicroRNA Market, By Technology (Microarray, Real Time PCR, Next Generation Sequencing, and Others), By Application (Cardiovascular disease, Cancer, Neurological disease, Infectious disease, Immunological disorder, and Others), By End-Users (Pharmaceutical & Biotechnology Companies, Research Institutes, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2032”

Before purchasing this report, request a sample or make an inquiry by clicking the following link:

https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/5012

Key Market Insights from the report:

MicroRNA Market accounted for US$ 728.23 million in 2022 and is estimated to be US$ 3844.3 million by 2032 and is anticipated to register a CAGR of 16.0%. The MicroRNA Market is segmented based on Technology, Application, and Region.

·         Based on Technology, MicroRNA Market is segmented into microarray, real time PCR, next generation sequencing, and others.

·         Based on Application, MicroRNA Market is segmented into cardiovascular disease, cancer, neurological disease, infectious disease, Immunological disorder, and others.

·         Based on End-Users, MicroRNA Market is segmented into pharmaceutical & biotechnology companies, research institutes, and others.

·         By Region, the MicroRNA Market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East & Africa.

Competitive Landscape & their strategies of MicroRNA Market:

The prominent players operating in the MicroRNA Market includes, Thermo Fisher Scientific, Illumina, QIAGEN, NEB, Takara Bio, Agilent Technologies, NanoString Technologies Inc., Bio-Rad Laboratories, Roche, GeneCopoeia, and others.

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

 

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

To know more

Contact Us:

Sales

Prophecy Market Insights

  1 860 531 2701

Email- sales@prophecymarketinsights.com

Website- www.prophecymarketinsights.com

 

Comments

Post a Comment

Popular posts from this blog

Humanized Liver Mice Model Market is estimated to be US$ 133.72 billion by 2030 with a CAGR of 5.30% during the forecast period

Image
Humanized Liver Mice Model Market   accounted for US$ 78.64 million in 2020 and is estimated to be US$ 133.72 million by 2030 and is anticipated to register a CAGR of 5.30%.  A lot of studies are underway to create novel humanized liver mouse models. Initially, liver mice models were created by implanting human liver cells or hepatic cancer cells into basic immune-deficient mice. The results, however, were inconsistent and unreliable. As a result, immune-deficient mice were developed, which spontaneously destroy the mice liver, allowing human liver cells to proliferate and replace it, resulting in stable humanized liver mice models. For example, a number of research projects are looking into using PPARalfa and AFC8-based mice models to develop humanized liver mice models. The report "Global Humanized Liver Mice Model Market, By Model (uPA-SCID, FRG KO Mice, TK-NOG Mice  and Other Models) By Application (Pharmacokinetics Studies, In-vivo Liver Toxicity Testing, Drug Metabolism Stud
Read more

Monkeypox Disease Diagnostics Market - The abrupt global expansion of the monkeypox virus has increased the demand for monkeypox diagnostics.

Image
  The virus that causes smallpox and the Monkeypox both belong to the same family of viruses. Two outbreaks of a disease resembling the pox in groups of monkeys used for study led to the discovery of monkeypox in 1958. However, it has been observed in various parts of the world except Africa, where it is primarily found. It results in symptoms that resemble the flu, such as fever, chills, and a rash that might take weeks to go away. Even though instances of monkeypox are uncommon, they are growing in Africa and other areas where they have never before occurred. The fact that monkeypox is a rare disease may lead a healthcare provider to first rule out other rash infections, such measles or chickenpox. A tissue sample from an open sore is the first step in the medical professional's diagnosis of monkeypox (lesion). After that, send to a lab for PCR (Polymerase Chain Reaction). Additionally, blood is drawn to test for antibodies or the monkeypox virus. Currently, there is no licens
Read more

Bipolar Disorder Market is estimated to be US$ 6.7 billion by 2030 with a CAGR of 2.3% during the forecast period

Image
Bipolar Disorder Market   accounted for US$ 5.3 billion in 2020 and is estimated to be US$ 6.7 billion by 2030 and is anticipated to register a CAGR of 2.3%. Bipolar disorder known as manic depression is a mental illness that brings low moods and severe high moods, thinking, changes in sleep and have periods in which they feel overly happy and energized and other side feel very sad, hopeless and sluggish. Bipolar disorder can cause severe disruption to a person’s life which can be treated with appropriate treatment and support. The report "   Global Bipolar Disorder Market, By Disorder (Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder), By Drug Class (Mood Stabilizer, Anticonvulsant, Antipsychotic Drugs, Antidepressant Drugs, and Antianxiety Drugs), By Mechanism of Action (Serotonin-Norepinephrine Reuptake Inhibitors, Selective Serotonin Reuptake Inhibitors, Monoamine Oxidase Inhibitors, Tricyclic Antidepressants, Beta Blockers, and Benzodiazepines), By Region (North
Read more